Home / Technology / EndoQuest Receives FDA Approval to Initiate Final Stage of PARADIGM Trial

EndoQuest Receives FDA Approval to Initiate Final Stage of PARADIGM Trial

EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced that the U.S. Food and Drug Administration (FDA) ha…

HOUSTON–(BUSINESS WIRE)–EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved initiation of the next and final stage of its pivotal mu… [4478 chars]

Source: Business Wire | Published: 2026-01-15T15:00:00Z

Credit: Business Wire

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *